Food Allergy Market Analysis 2026

According to Cognitive Market Research, the global Food Allergy Market size will be USD 42614.8 million in 2025. It will expand at a compound annual growth rate (CAGR) of 5.80% from 2025 to 2033.

• North America held the major market share for more than 37% of the global revenue with a market size of USD 15767.48 million in 2025 and will grow at a compound annual growth rate (CAGR) of 3.6% from 2025 to 2033.
• Europe accounted for a market share of over 29% of the global revenue with a market size of USD 12358.29 million in 2025 and will grow at a compound annual growth rate (CAGR) of 4.1% from 2025 to 2033.
• APAC held a market share of around 24% of the global revenue with a market size of USD 10227.55 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2033.
• South America has a market share of more than 3.8% of the global revenue with a market size of USD 1619.36 million in 2025 and will grow at a compound annual growth rate (CAGR) of 4.8% from 2025 to 2033.
• The Middle East had a market share of around 4% of the global revenue and was estimated at a market size of USD 1704.59 million in 2025. It will grow at a compound annual growth rate (CAGR) of 5.1% from 2025 to 2033.
• Africa had a market share of around 2.2% of the global revenue and was estimated at a market size of USD 937.53 million in 2025. It will grow at a compound annual growth rate (CAGR) of 5.5% from 2025 to 2033.
• Oral Immunotherapy is the fastest growing segment of the Food Allergy Market industry

Introduction of the Food Allergy Market

The diagnosis, treatment, and management of unfavourable immunological reactions brought on by particular foods are the focus of the food allergy market. These allergies need to be properly identified and carefully managed through diet because they can result in mild to severe reactions, including anaphylaxis. Diagnostic equipment, medications such as immunotherapies and antihistamines, and food items free of allergens are all available on the market. The increasing frequency of food allergies, increased public knowledge, and improvements in diagnostic technologies all have an impact on market dynamics. However, there are obstacles, such as exorbitant treatment expenses, a shortage of specialists, and uneven labelling laws. With more research and innovation, the industry is growing internationally, particularly in developed areas with stronger healthcare systems and high consumer demand for safe food substitutes.

In March 2025, Celltrion announced that the FDA authorised OMLYCLO® (omalizumab-igec) as the first biosimilar to XOLAIR® (omalizumab) that can be used interchangeably to treat CRSwNP, moderate to severe asthma, IgE-mediated food allergies, and CSU. https://www.celltrion.com/en-us/company/media-center/press-release/3778#:~:text=JERSEY%20CITY%2C%20N.J.%2C%20March%209,to%20severe%20persistent%20asthma%2C%20chronic/"

Impact of Trump Tariffs on the Food Allergy Market

The Trump tariffs may indirectly affect the Food Allergy Market. Tariffs on steel and aluminium, two raw materials used in the production of medical devices like epinephrine auto-injectors, may raise the cost of producing allergy treatment devices, which could ultimately result in higher pricing for final consumers. A large number of diagnostic instruments and parts used in allergy testing, including reagents, test kits, and lab equipment, are supplied from around the world. Food allergy diagnostics' accessibility and affordability may be indirectly impacted by tariffs on medical imports, which could increase expenses for labs and clinics.

Tariffs on imported components or lab equipment may result in higher operating expenses for biotech and pharmaceutical companies engaged in developing allergy treatments, which could impede advancements in molecular diagnostics or oral immunotherapy. Import taxes on agricultural items (such as dairy, soy, or nuts) may cause supply chain disruptions for hypoallergenic or speciality allergen-free food products, which may have an indirect effect on supply and cost in the food allergy dietary market.

The adoption of food allergy diagnostics and treatment options may be slowed by broader geopolitical tensions and retaliatory tariffs that affect foreign investment in healthcare infrastructure, especially in emerging nations.?

The global growth of the food allergy market may be hampered if tariffs are reinstated or prolonged in the future, particularly in emerging nations. Costlier imports of allergy-free products, testing equipment, and treatment devices may restrict market expansion. This could hinder innovation, make allergy treatment programs less affordable for consumers, and make them less scalable in areas where customers are price-sensitive.?